MIRA Pharmaceuticals
MIRA | NASDAQ
$0.63
-$0.03 (-4.52%)
At close: Nov 16, 2026, 4:00 PM ET
$0.63
$0.00 (+0.16%)
After-hours:
Nov 16, 2026, 4:10 PM ET
MIRA Pharmaceuticals Company Profile
Company profile explainedCompany Profile
MIRA Pharmaceuticals, Inc. operates as a biopharmaceutical enterprise currently in the clinical development phase. Its main objective involves the creation and market introduction of a novel synthetic tetrahydrocannabinol (THC) analog. This compound is undergoing investigation for its potential to address anxiety and the cognitive impairments frequently observed in adult patients suffering from early-stage dementia. The firm's lead candidate, MIRA1a, is a synthetic cannabinoid analog engineered to alleviate both anxiety and chronic pain through its interaction with cannabinoid type 1 and type 2 receptors. Originally established in 2020 as MIRA1a Therapeutics, Inc., MIRA Pharmaceuticals, Inc. maintains its headquarters in Baltimore, Maryland.
Key Executives
| Name | Position |
|---|---|
| Erez Aminov | Chief Executive Officer & Chairman |
| Andriy Mushak | Chief Financial Officer |
| Itzchak Angel | Chief Scientific Advisor |
Latest SEC Filings
| Date | Type | Title |
|---|---|---|
| Oct 28, 2026 | 8-K | Current Report |
| Oct 22, 2026 | 8-K | Current Report |
| Sep 17, 2026 | 8-K | Current Report |
| Sep 16, 2026 | 8-K | Current Report |
| Sep 01, 2026 | 8-K | Current Report |
| Aug 12, 2026 | 10-Q | Quarterly Report |
| Aug 06, 2026 | 8-K | Current Report |
| Jul 31, 2026 | 8-K | Current Report |
| Jul 28, 2026 | DEF 14A | Filing |
| Jul 10, 2026 | 8-K | Current Report |
MIRA Pharmaceuticals
| Country | United States |
| IPO Date | Aug 3, 2023 |
| Industry | Drug Manufacturers - General |
| Sector | Healthcare |
| Employees | 2 |
| CEO | Erez Aminov |
Contact Details
1200 Brickell Avenue Miami,
Florida 33131 United States
Stock Details
| Ticker Symbol | MIRA |
| Exchange | NASDAQ |
| Fiscal Year | January - December |
| Reporting Currency | USD |
| CIK Code | 0001904286 |
| CUSIP Number | 60458C104 |
| ISIN Number | US60458C1045 |
| SIC Code | 2834 |
Add to Watchlist
Select watchlists to add or remove MIRA